首页> 外文期刊>BMC Cancer >Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification
【24h】

Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification

机译:泰国东北胆管癌患者患者的疗效术后生存,根据解剖学和形态学分类

获取原文
           

摘要

Cholangiocarcinoma (CCA) has been categorized based on tumor location as intrahepatic (ICCA), perihilar (PCCA) or distal (DCCA), and based on the morphology of the tumor of the bile duct as mass forming (MF), periductal infiltrating (PI) or intraductal (ID). To date, there is limited evidence available regarding the survival of CCA among these different anatomical and morphological classifications. This study aimed to evaluate the survival rate and median survival time after curative surgery among CCA patients according to their anatomical and morphological classifications, and to determine the association between these classifications and survival. This study included CCA patients who underwent curative surgery from the Cholangiocarcinoma Screening and Care Program (CASCAP), Northeast Thailand. The anatomical and morphological classifications were based on pathological findings after surgery. Survival rates of CCA and median survival time since the date of CCA surgery and 95% confidence intervals (CI) were calculated. Multiple cox regression was performed to evaluate factors associated with survival which were quantified by hazard ratios (HR) and their 95% CIs. Of the 746 CCA patients, 514 had died at the completion of the study which constituted 15,643.6 person-months of data recordings. The incidence rate was 3.3 per 100 patients per month (95% CI: 3.0–3.6), with median survival time of 17.8?months (95% CI: 15.4–20.2), and 5-year survival rate of 24.6% (95% CI: 20.7–28.6). The longest median survival time was 21.8?months (95% CI: 16.3–27.3) while the highest 5-year survival rate of 34.8% (95% CI: 23.8–46.0) occurred in the DCCA group. A combination of anatomical and morphological classifications, PCCA ID, was associated with the longest median survival time of 40.5?months (95% CI: 17.9–63.0) and the highest 5-year survival rate of 42.6% (95% CI: 25.4–58.9). The ICCA MF combination was associated with survival (adjusted HR: 1.45; 95% CI: 1.01–2.09; P?=?0.013) compared to ICCA ID patients. Among patients receiving surgical treatment, those with PCCA ID had the highest 5-year survival rate, which was higher than in groups classified by only anatomical characteristics. Additionally, the patients with ICCA MF tended to have unfavorable surgical outcomes. Showed the highest survival association. Therefore, further investigations into CCA imaging should focus on patients with a combination of anatomical and morphological classifications.
机译:胆管癌(CCA)基于肿瘤位置作为肝内(ICCA),Perihilar(PCCA)或远端(DCCA),并基于胆管肿瘤的形态,作为大规模成型(MF),潜水浸润(PI )或Intr发生(ID)。迄今为止,在这些不同的解剖学和形态学分类中,CCA存活的证据有限。本研究旨在根据其解剖和形态学分类评估CCA患者疗法手术后的存活率和中位生存时间,并确定这些分类和生存之间的关联。该研究包括CCA患者,从胆管癌筛查和护理计划(Cascap),东北部门接受疗法手术。解剖学和形态学分类是基于手术后病理发现。 CCA和中位生存时间的存活率计算自CCA手术和95%置信区间(CI)以来。进行多元COX回归以评估与存活相关的因子,其通过危险比(HR)和其95%顺式定量。在746名CCA患者中,514岁在研究完成时死亡,该研究构成了15,643.6人的数据记录。每月的发病率为每月3.3例(95%CI:3.0-3.6),中位存活时间为17.8?月份(95%CI:15.4-20.2),5年生存率为24.6%(95%) CI:20.7-28.6)。最长的中位生存时间为21.8?月(95%CI:16.3-27.3),而DCCA集团发生了34.8%的5年生存率为34.8%(95%CI:23.8-46.0)。解剖学和形态学分类,PCCA ID的组合与40.5个月的最长中位数生存时间相关联(95%CI:17.9-63.0),最高5年生存率为42.6%(95%CI:25.4- 58.9)。与ICCA ID患者相比,ICCA MF组合与存活相关(调整后的HR:1.45; 95%CI:1.01-2.09; p?= 0.013)。在接受手术治疗的患者中,患有PCCA ID的患者的存活率最高,其余的率高于仅由解剖特征分类的组。此外,ICCA MF的患者往往具有不利的手术结果。展示了最高的生存协会。因此,进一步调查CCA成像应专注于患者组合的解剖学和形态学分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号